Autopsy report · NCT00406653
A Study of Abatacept in Patients With Active Crohn's Disease
Cause of deathFunding or business
“Sponsor Decision”
Life of this trial
- Ran for about 2 years 11 months before it stopped.
- 451 participants enrolled.
- Results were posted on the registry 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Bristol-Myers Squibb
- Sponsor type
- Industry
- Conditions
- Crohn's Disease
- Interventions
- abatacept; placebo; abatacept
- Participants
- 451
- Sites
- 101
- Countries
- Australia, Belgium, Brazil, Canada, Czechia, Denmark, France, Germany, India, Italy, Mexico, Netherlands and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.